Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol

The New England Journal of Medicine
W S ColucciE Braunwald

Abstract

We compared the initial and long-term effects of the beta-adrenergic agonist pirbuterol in 12 patients with chronic congestive heart failure. The drug's initial effect was a 35 per cent increase in cardiac index, but there was no significant change in heart rate or mean arterial pressure. After one month of therapy, the mean cardiac index and ejection fraction had returned to base-line values, and no clinical effect was evident in most patients. This apparent tolerance was not accompanied by changes in heart rate, blood pressure, or body weight, and it occurred in the presence of therapeutic drug levels during long-term therapy. The density of beta-adrenergic receptors on lymphocytes from patients treated with pirbuterol was significantly depressed as compared with that of patients with heart failure of comparable severity but not treated with pirbuterol. We conclude that tolerance to the hemodynamic and clinical effects of pirbuterol develops during long-term administration; this tolerance may be related to a decrease in myocardial or vascular beta-adrenergic receptors or both.

References

Jun 1, 1977·British Journal of Clinical Pharmacology·I C PatersonI W Grant
Oct 26, 1978·The New England Journal of Medicine·S P GalantP A Insel
Aug 20, 1977·Lancet·S T HolgateA E Tattersfield
May 1, 1977·The Journal of Allergy and Clinical Immunology·J W JenneF J Wall
Feb 1, 1978·The American Journal of Cardiology·J A Thomas, B H Marks
Dec 21, 1978·The New England Journal of Medicine·J R BenottiA A Alousi
Oct 1, 1976·Biomedical Mass Spectrometry·F C Falkner, H M McIlhenny
Jan 1, 1976·The Journal of Clinical Investigation·L T WilliamsR J Lefkowitz
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen
Feb 1, 1980·The American Journal of Cardiology·W S ColucciE Braunwald
Apr 1, 1981·The American Journal of Medicine·L SteinM H Weinberger
Aug 1, 1980·The American Journal of Medicine·D A UnverferthC V Leier

❮ Previous
Next ❯

Citations

Jan 1, 1993·Clinical Cardiology·A Om, M L Hess
Mar 1, 1995·Clinical Cardiology·M Metra, L Dei Cas
Jan 1, 1983·European Journal of Clinical Pharmacology·D N Sharpe, R Coxon
Jan 1, 1989·European Journal of Clinical Pharmacology·I S AnandE B Raftery
Jan 1, 1991·Heart and Vessels. Supplement·E M GilbertM R Bristow
Feb 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·C S GarrardM Piepoli
Apr 1, 1990·Cardiovascular Drugs and Therapy·A V MattioliG Mattioli
Jan 1, 1989·Basic Research in Cardiology·G Broderick, S I Rajfer
Nov 26, 1991·European Journal of Pharmacology·J T SullebargerC S Liang
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·E A Stone
May 1, 1995·International Journal of Cardiology·A L Clark, A J Coats
Nov 1, 1989·Journal of the American College of Cardiology·K M BorowM H Yacoub
Oct 1, 1993·Journal of the American College of Cardiology·A M Feldman
Jan 1, 1989·Domestic Animal Endocrinology·S E Mills, A L Orcutt
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·V Sbirrazzuoli, P Lapalus
Jan 1, 1983·Journal of the American College of Cardiology·A M Watanabe
Nov 1, 1983·Journal of the American College of Cardiology·M Packer
Jun 1, 1984·Journal of the American College of Cardiology·E Braunwald, W S Colucci
Jul 1, 1982·The New England Journal of Medicine·H J Motulsky, P A Insel
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
May 24, 1984·The New England Journal of Medicine·S I RajferL I Goldberg
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D C WhiteW J Koch
Aug 1, 1990·British Journal of Clinical Pharmacology·D G Waller
Jan 1, 1997·Fundamental & Clinical Pharmacology·L Cloarec-Blanchard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.